On the other hand, epigenetic methylation at the promoter of the FAS death receptor in certain cancers reduces NF-κB-dependent activation of FAS expression, thus contributing to tumor cell survival by reducing levels of the proapoptotic FAS protein [57]. This evidence concerns the gene FAS and cancer.